Sleepiz One+

by Sleepiz  · Based in Switzerland →Contactless Monitoring for Senior Care
Geriatrics Pulmonology Sleep Medicine

Contact for pricing
Regulatory Status Disclosed

Overview

Sleepiz One+ is an FDA-cleared, contactless remote patient monitoring device that utilizes radar technology to collect biometric data and record vital signs from a patient’s bedside. It provides comprehensive respiration and heart rate monitoring for chronic conditions, including sleep apnea screening. The device is designed for ease of use, allowing for quick installation and seamless data transmission via a cellular module. It measures macro and micro-motions from heart contractions and breathing patterns with medical-grade accuracy, transforming these signals into actionable data using proprietary AI. Sleepiz One+ aims to provide patient-centric disease management through seamless integration of contactless monitoring into people’s homes, offering an alternative to traditional, often cumbersome, diagnostic methods like polysomnography. It is intended for use by healthcare professionals in clinical settings or by patients and their caregivers in a home environment.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Contactless monitoring (radar technology)
  • Measures respiration rate
  • Measures heart rate
  • Sleep apnea screening
  • Remote patient monitoring
  • AI-powered data analysis
  • Web application for data access and analysis
  • Easy setup and deployment
  • Clinically validated
  • HIPAA compliant

Use Cases

  • Long-term monitoring of chronic respiratory diseases
  • Sleep apnea diagnosis and screening
  • Early detection of patient deterioration
  • Hospital at Home programs
  • Clinical trials and research studies
  • Senior care and assisted living facilities

What Physicians Need to Know

Cardiac Monitoring Integration
Sleepiz One+ is a contactless medical device that measures heart rate and respiration rate in adult patients at rest or during sleep. It integrates with Remote Patient Monitoring (RPM) and clinical study platforms, allowing healthcare professionals to access overnight vital sign data and presence logs via the Sleepiz cloud software for retrospective review and patient management.
Arrhythmia Detection Accuracy
The device measures heart rate with a 96% accuracy rate compared to gold standard methods.
AHA/ACC Guideline Alignment
While not explicitly stating alignment with AHA/ACC guidelines, the continuous monitoring of heart rate and respiration rate is crucial for assessing overall patient health and detecting early deterioration, which aligns with the principles of proactive cardiovascular care.
Physician Tip

Sleepiz One+ offers a valuable tool for contactless, long-term monitoring of heart rate and respiration rate, particularly beneficial for remote patient monitoring and clinical studies. Its high accuracy in vital sign measurement can aid in the early detection of physiological deterioration. Physicians should note that while it provides continuous data for review, it is not designed for real-time alarming in acute, life-threatening situations. It can be particularly useful for patients with chronic conditions, including cardiovascular and respiratory diseases, to track disease progression or remission and enable timely interventions.

The Sleepiz One+ seamlessly integrates into Remote Patient Monitoring (RPM) and clinical study platforms, providing healthcare professionals with access to comprehensive respiration and heart rate monitoring capabilities. Data is accessible via the Sleepiz cloud software for retrospective review and patient management. The device can also optionally integrate with additional Bluetooth devices, such as SpO2 sensors, to enhance monitoring capabilities.

Details

Category Cardiology AI, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing
  • Physicians can reimburse the use of the device using current procedural terminology (CPT) codes for remote patient monitoring; Sleepiz One+ allows for 16 out of 30 days of measurements for CPT billing purposes
DeploymentWall-mounted or bedside table placement, Wi-Fi connectivity
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Sleepiz One+ received FDA Class II 510(k) clearance in October 2023. This clearance allows physicians to prescribe the device for monitoring vital signs and sleep apnea screening in adult patients.

Integrations
EHR Not specified
Specialties Geriatrics, Pulmonology, Sleep Medicine

What the Web Says

The Sleepiz One+ is a contactless remote patient monitoring device that has received FDA 510(k) clearance and CE mark certification. It uses radar technology to measure vital signs like heart rate and respiration rate, as well as detect sleep patterns and bed presence, without requiring any wearables. The device is designed for home use and aims to provide a more comfortable and less intrusive alternative to traditional sleep monitoring methods.

Overall: Positive

Strengths

  • Contactless and non-invasive, improving patient comfort and compliance.
  • Accurate in measuring breathing rate (99%) and heart rate (96%) compared to gold standard methods.
  • Valid diagnostic tool for moderate to severe Obstructive Sleep Apnea (OSA), especially with an added SpO2 sensor.
  • Easy to install and use, with a plug-and-play system and automatic cellular data transmission.
  • Enables long-term, continuous monitoring of vital signs at home, providing comprehensive data for healthcare professionals.
  • Facilitates remote patient monitoring and can be reimbursed by physicians using CPT codes.

Limitations

  • Some users expressed concerns about data protection and being technically challenged.
  • The ability to self-check device functionality was noted as missing in early testing.
  • Fear of tripping over the device at night and its perceived inconvenience during the day were mentioned.
  • Comprehensibility of the report could be improved with more text and explanation.
  • May slightly underestimate AHI when an SpO2 sensor is added.
  • Still struggles to distinguish between sleep and wakefulness, which is essential for accurate AHI estimation.

Based on reviews from: Sleepiz.com, PMC, Xtalks, ResearchGate, PubMed, Galaxus, Karger Publishers

Last updated: 2026-07-02

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Sleepiz One+

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

OEM News
FDA Clears Sleepiz's Contactless Remote Patient Monitoring Device
Sleepiz One+, a contactless device for remote patient monitoring, received FDA 510(k) clearance, enabling comprehensive respiration and heart rate monitoring for healthcare professionals and patients with chronic respiratory diseases. The device boasts 99% accuracy in breathing rate and 96% in heart rate measurements compared to gold standard methods.
2023-12
Sleep Review
FDA Clears Bedside Device for Contactless Remote Patient Monitoring
The Sleepiz One+, a contactless remote patient monitoring device, has received FDA 510(k) clearance, allowing it to collect biometric data and vital signs from a user's bedside while they sleep. This clearance facilitates its integration into remote patient monitoring and clinical study platforms, offering enhanced insights for healthcare professionals.
2023-10
Xtalks
Sleepiz's At Home Sleep Monitoring Device Wins FDA Clearance - Xtalks
Sleepiz AG has been granted US FDA Class II 510(k) clearance for its Sleepiz One+ device, which measures vital signs during sleep using radar technology. This clearance allows physicians to prescribe the device for monitoring vital signs and screening for sleep apnea, and it can be reimbursed via remote patient monitoring codes.
2023-10
Medical Alley
Sleepiz AG Lands FDA 510(k) Clearance for Contactless Remote Patient Monitoring Device Measuring Vital Signs
Sleepiz, a Zurich-based medical technology company, announced FDA Class II 510(k) clearance for its Sleepiz One+ device, a contactless bedside patient monitor. This clearance enables seamless integration into Remote Patient Monitoring (RPM) and clinical study platforms, empowering healthcare professionals with comprehensive respiration and heart rate monitoring capabilities.
2023-10
Startup Ticker
FDA approval for SleepizOne+ device - Startup Ticker
Sleepiz One+ has received FDA Class II 510(k) clearance in the US, in addition to its CE class IIa medical device certification in Europe. This regulatory approval opens doors for its integration into Remote Patient Monitoring (RPM) and clinical study platforms, allowing physicians to prescribe the device for patients.
2023-10
PubMed Central (PMC)
Validation of the Sleepiz One + as a radar-based sensor for contactless diagnosis of sleep apnea - PMC
A study published in May 2024 concluded that the Sleepiz One+ device is a valid diagnostic tool for patients with moderate to severe Obstructive Sleep Apnea (OSA) and can be easily used in a home environment. The study found a strong correlation between Sleepiz-AHI and PSG-AHI, with high sensitivity and specificity for OSA detection.
2024-05
PubMed Central (PMC)
Clinical validation of a contactless respiration rate monitor - PMC - NIH
A clinical study validated the Sleepiz One+ as a contactless respiration monitor, demonstrating excellent agreement with the thoracic effort belt for instantaneous breathing rate. The device offers improved patient comfort and enables long-term respiration monitoring, providing a more comprehensive picture of a patient's status.
2023-03
Sleepiz.com
Sleepiz for Clinical Trials & Pharma Research
Sleepiz One+ is utilized in clinical trials and pharma research for continuous and touchless sleep monitoring at home, offering objective sleep measurements. It is 510(k) cleared, CE Mark IIa certified, and validated against polysomnography, demonstrating high participant compliance with minimal setup.
2024-04

Videos

Product demos, reviews, and walkthroughs for Sleepiz One+.

View all on YouTube

Frequently Asked Questions

Sleepiz One+ utilizes a radar-based, non-contact sensor to monitor vital signs like breathing and heart rate during sleep. Its AI algorithms analyze these physiological signals to detect sleep apnea events, including central and obstructive apneas, and can provide insights into heart rate variability, which is relevant for assessing cardiovascular strain during sleep.
The Sleepiz One+ is designed for home use, with data automatically uploaded to a secure cloud platform. Physicians can access comprehensive reports through a dedicated portal, which include sleep stages, apnea-hypopnea index (AHI), heart rate trends, and oxygen desaturation events. The reports are structured to provide clear, actionable insights for cardiology patients.
Sleepiz One+ offers a non-contact, unobtrusive alternative to traditional PSG, which can be cumbersome. While PSG remains the gold standard for comprehensive sleep studies, Sleepiz One+ provides validated accuracy for detecting sleep apnea and offers continuous heart rate monitoring, which can be particularly useful for cardiology patients. It aims to improve patient compliance due to its ease of use compared to other HSATs.
Pricing details for Sleepiz One+ are typically provided upon inquiry to Sleepiz directly, as they can vary based on volume and specific clinic needs. Regarding reimbursement, it's essential to check with local and national coding guidelines, as the landscape for AI-powered home monitoring devices is evolving. Sleepiz may offer guidance on applicable CPT codes for home sleep apnea testing.
While Sleepiz One+ is effective for detecting sleep apnea and monitoring heart rate, it may have limitations in precisely characterizing complex cardiac arrhythmias or other highly specialized cardiac conditions that require direct ECG monitoring. It's generally suitable for a broad patient population, but physicians should consider individual patient needs and comorbidities when determining its appropriateness.
Sleepiz One+ adheres to strict data security and privacy regulations, including GDPR and HIPAA compliance. All data is encrypted during transmission and storage, and access is restricted to authorized personnel. The AI processing is performed on anonymized data where possible, and robust safeguards are in place to protect patient information.
Sleepiz provides comprehensive technical support and training resources for healthcare professionals. This includes user manuals, online tutorials, and dedicated support channels to assist with device setup, data interpretation, and integration into clinical workflows. They aim to ensure physicians can confidently and effectively use the device for their cardiology patients.

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-07-01 | First Added: 2026-07-01

Investors who backed Sleepiz One+

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.